...
首页> 外文期刊>OncoTargets and therapy >circGFRA1 Enhances NSCLC Progression by Sponging miR-188-3p
【24h】

circGFRA1 Enhances NSCLC Progression by Sponging miR-188-3p

机译:CircGFRA1通过海​​绵MIR-188-3P增强NSCLC进展

获取原文
           

摘要

Background: Lung cancer continues to be one of the most dangerous tumors around the world. It is an urgency to explore the molecular mechanism of non-small cell lung cancer (NSCLC) progression for developing novel therapeutic approaches. Circular RNA (circRNA) is a novel type of non-coding RNA with a stable closed loop structure. Abnormally expressed circRNAs have been found in many kinds of cancer including NSCLC. Methods and Results: The expression of circGFRA1 and miR-188-3p was detected in NSCLC tissues by RT-qPCR and it was found that circGFRA1 was highly expressed and miR-183-3p was lowly expressed in NSCLC tissues. In NSCLC cell lines, we confirmed that circGFRA1 acted as an miR-188-3p sponge using dual-luciferase reporter assay and RNA immunoprecipitation (RIP) analysis. Overexpression of cirGFRA1 enhanced NSCLC progression while miR-188-3p overexpression inhibited it by CCK8 and colony formation analysis. In vivo tumor xenograft model, circGFRA1 and miR-188-3p synergistically regulated the proliferation of NSCLC tumors. Mechanistic study indicated that circGFRA1 and miR-188-3p regulated the proliferation of NSCLC cells at least through PI3K/AKT signaling pathway. Conclusion: Our study elaborated a novel circGFRA-miR-188-3p-PI3K/AKT regulatory pathway, providing a potential diagnostic biomarker and therapeutic target for NSCLC.
机译:背景:肺癌仍然是世界上最危险的肿瘤之一。探讨非小细胞肺癌(NSCLC)进展的迫切性,以发展新型治疗方法。圆形RNA(CircrNA)是一种新型的非编码RNA,具有稳定的闭环结构。在包括NSCLC的许多癌症中发现了异常表达的Circrnas。方法和结果:通过RT-QPCR在NMSCLC组织中检测到CiNCGFRA1和MIR-188-3P的表达,发现CiNGFRA1高表达,MIR-183-3P在NSCLC组织中低于表达。在NSCLC细胞系中,我们证实CINCGFRA1用双荧光素酶报告器测定和RNA免疫沉淀(RIP)分析作用为MIR-188-3P海绵。 CCK8和菌落形成分析抑制MiR-188-3P过表达,致粘性的NSCLC进展增强了NSCLC进展。体内肿瘤异种移植模型,CIMGFRA1和MIR-188-3P协同调节NSCLC肿瘤的增殖。机械研究表明,NiCGFRA1和MIR-188-3P至少通过PI3K / AKT信号通路调节NSCLC细胞的增殖。结论:我们的研究详细阐述了一种新的CINCGFRA-MIR-188-3P-PI3K / AKT调节途径,为NSCLC提供了潜在的诊断生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号